• Health & Medicine
• Science & Technology

2023 roundup: 5 of our most important cancer research stories of the year

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

18 December 2023

• Health & Medicine

Thousands of women offered anastrozole to help prevent breast cancer

The MHRA has licensed anastrozole as a way to prevent breast cancer in almost 300,000 women. Our trial showed that it can halve their risk. The MHRA has licensed anastrozole as a way to prevent breast cancer in almost 300,000 women. Our trial showed that it can halve their risk.

7 November 2023

• For Researchers

The path to prevention is paved with biological insight

Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important… Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important…

30 October 2023

• Health & Medicine

More than 2 million years of life are lost to cancer each year

Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK. However, the data also showed that thanks to innovation and research, we are making progress in beating cancer.   Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK. However, the data also showed that thanks to innovation and research, we are making progress in beating cancer.  

11 October 2023

• Health & Medicine

New study to investigate breast cancer in ethnic minority groups

A new Cancer Research UK-funded study aims to shed light on the variation in breast cancer across different ethnic minority groups.  A new Cancer Research UK-funded study aims to shed light on the variation in breast cancer across different ethnic minority groups. 

11 July 2023

• Charity News
• Health & Medicine

Research project launched in memory of Sarah Harding recruits first participant

A new breast cancer research project, launched in memory of Girls Aloud singer Sarah Harding, has recruited its first participant. A new breast cancer research project, launched in memory of Girls Aloud singer Sarah Harding, has recruited its first participant.

27 June 2023

• Science & Technology

How clues from crystals might help us prevent the overtreatment of DCIS

New research may have found a way we can predict which cases of DCIS could develop into invasive breast cancer and thus require treatment, reducing the burden of overtreatment in future New research may have found a way we can predict which cases of DCIS could develop into invasive breast cancer and thus require treatment, reducing the burden of overtreatment in future

20 June 2023

• Health & Medicine

Risk of dying from early invasive breast cancer down by around two-thirds in the last 20 years

Today, more than 90% of women diagnosed with early-stage breast cancer will survive for 5 years or more, according to research we funded. Today, more than 90% of women diagnosed with early-stage breast cancer will survive for 5 years or more, according to research we funded.

13 June 2023

• Science & Technology

How MRI add-ons could accelerate the development of new treatments

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

9 May 2023

• Health & Medicine

Olaparib approved for 800 prostate and breast cancer patients in England

Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England.  Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England. 

11 April 2023

• Health & Medicine

Contraception and cancer – a look behind the headlines

You may have heard about a new study into contraception and cancer. New information about cancer risks can be hard to apply to everyday life, so let’s break this research down and see what it means. You may have heard about a new study into contraception and cancer. New information about cancer risks can be hard to apply to everyday life, so let’s break this research down and see what it means.

21 March 2023

• Personal Stories

Lessons from the green: How sports psychology helped a top golf pro cope with cancer

Lysa Jones, a golf coach and pro, talks about how her experiences in the sport helped her to cope with her breast cancer diagnosis. Lysa Jones, a golf coach and pro, talks about how her experiences in the sport helped her to cope with her breast cancer diagnosis.

16 March 2023